Navigation Links
ViroPharma Announces Presentation of Additional HCV-796 Data at,Meeting of The European Association for the Study of the Liver

on with peg-IFN has been completed. Combination therapy including HCV-796 was found to be generally well tolerated. The observed safety profile supports the evaluation of HCV-796 in studies of longer duration.

-- Adverse events across all dose cohorts were generally mild to moderate in severity and were characteristic of the known side effects of interferons.

-- Adverse events that occurred at a frequency of greater than 15 percent across all dose cohorts of HCV-796 plus peg-IFN and peg-IFN alone included headache, chills, myalgias, fever, pain, arthralgia and rash.

-- There were two reports of serious adverse events: one in the placebo arm (pneumonia), and one in the 1000 mg combination cohort (seizure and rhabdomyolysis in a subject receiving high dose methadone chronically).

-- The rate of discontinuation due to adverse events was low across the study. No patient discontinued due to adverse events in the 100, 250, or 500 mg dose cohorts. In the peg-IFN alone group, one patient discontinued due to hypertension; of those that received 1000 mg HCV-796 plus peg-IFN, three patients discontinued due to either vasovagal syncope after a blood draw, rash, or seizure and rhabdomyolysis (in a subject receiving high dose methadone chronically).

-- No dose-limiting toxicities were identified across the range of study doses.

Genetic Sequencing

NS5B sequencing was performed on 36 subjects (11 on peg-IFN alone; 25 HCV- 796 and peg-IFN). Consistent with data from the Phase 1b study of HCV-796 as monotherapy, the only variant of importance detected in patients receiving HCV-796 was a C316Y variant known to have reduced susceptibility to HCV-796. Baseline sequencing did not find any variation from wild type at this position. The C316Y variant was observed in 7 (28 percent) of patients on HCV- 796 plus peg-IFN, occurring less frequently than previously seen in patients receiving HCV-796 as monotherapy, and was not clearly associated w
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
4. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
5. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
Post Your Comments:
(Date:1/15/2014)... PALM BEACH GARDENS, Fla. , Jan. 15, 2014  In an ... C. difficile and TB in ambulances and other transport vehicles, an ... being used by rescue personnel for the first time. ... coming in contact with these deadly pathogens, West Palm ...
(Date:1/15/2014)... WOONSOCKET, R.I. , Jan. 15, 2014 MultiCell ... has filed a U.S. provisional patent application concerning composition ... formulations to achieve targeted tumor cell death.  ... very small noncoding double stranded RNA molecules (VSRNAs) which ...
(Date:1/15/2014)... Jan. 15, 2014 The Cadence Fitness & Health ... by the Medical Fitness Association, a non-profit organization assisting ... full potential. The Cadence Fitness & Health Center is ... and second in the Chicagoland area. "The ...
Breaking Medicine Technology:Superbugs No Longer Ride In Rescue Vehicles 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3Cadence Fitness & Health Center Certified as Medical Fitness Facility 2Cadence Fitness & Health Center Certified as Medical Fitness Facility 3
... 31, 2011 The Procter & Gamble Company (NYSE: ... joined its U.S. Sustainability Expert Advisory Panel (SEAP). The new ... Senior Manager, Clinton Global Initiative Dr. Howard Frumkin – ... Washington Terry Tamminen – Former Secretary, California Environmental Protection ...
... May 31, 2011 HeartSine Technologies, Inc, a ... its system warranty period to an exclusive 10 years on ... Public Access Defibrillator (PAD) for the ... currently is the fastest growing AED. The life of its ...
Cached Medicine Technology:P&G Welcomes New Members to U.S. Sustainability Expert Advisory Panel 2P&G Welcomes New Members to U.S. Sustainability Expert Advisory Panel 3HeartSine® Increases AED System Warranty to Longest in the Industry 2
(Date:4/18/2014)... new study in the American Journal of Preventive ... reveals a recurring pattern that could be leveraged to ... San Diego State University, the Santa Fe Institute, Johns ... searches (searches that included the term healthy and were ... from 2005 to 2012. They found that on average, ...
(Date:4/17/2014)... first genetic variant specifically associated with the risk ... 10-15 per cent of all breast cancer cases. ... cancer sub-type, called invasive lobular carcinoma, gives researchers ... particular kind of breast cancer, which can be ... (Thursday) in the journal PloS Genetics , ...
(Date:4/17/2014)... at the University of California, San Diego School of ... who have suffered a recent major loss are more ... adults. , The study is published in this month,s ... . , Because compassionate behaviors are associated with better ... offer insights into ways to improve the outcomes of ...
(Date:4/17/2014)... Rochelle, NY, April 17, 2014U.S. military personnel who ... plus impact" concussive traumatic brain injury (TBI) were ... evacuated for other medical reasons. Differences in measures ... depression 6-12 months after injury are reported in ... a peer-reviewed journal from Mary Ann Liebert, Inc., ...
(Date:4/17/2014)... discovering a new mechanism that allows blood to enter ... Irvine and the Salk Institute have opened the door ... brain damage. , A complex and devastating neurological condition, ... reason for disability in the U.S. The blood-brain barrier ... material into the brain, causing the permanent deficits in ...
Breaking Medicine News(10 mins):Health News:New research shows people are thinking about their health early in the week 2Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 2Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 3Health News:The ilk of human kindness 2Health News:Long-term effects of battle-related 'blast plus impact' concussive TBI in US military 2Health News:Study IDs new cause of brain bleeding immediately after stroke 2
... multinational corporation headquartered in Japan and the world,s ... of Toray Water Technology Laboratory (TWTL) in Singapore ... technologies. Nanyang Technological University (NTU),s Nanyang Environment and ... choice partner for its research activities in Singapore. ...
... Association (AUA) Foundation announced that Jennifer Dodson, MD, of ... AUA Foundation/NIDDK/NCI Surgeon-Scientist Award, offered by the AUA Foundation, ... Diseases (NIDDK) and the National Cancer Institute (NCI). ... have received the Surgeon-Scientist Award since the program began ...
... June 25, 2009, TIME: ... 722 12th St, NW, EVENT: ... town meeting to explain opposition to health care reform , ... on the 44th anniversary of Medicare., ...
... National Business Group on Health Recognizes HealthyQuest Program for ... 24 Quest Diagnostics Incorporated (NYSE: DGX ... and services, announced today that the National Business Group ... for Healthy Lifestyles Platinum Award to the company for ...
... CORTLANDT MANOR, N.Y., June 24 Polymedco, Inc. ... PATHFAST immunoassay analyzer, manufactured by Mitsubishi Chemical Medience ... of care system utilizes a chemiluminescent technology combined ... that allows this system to report highly accurate ...
... 2009) For Professor Chad Mirkin, good things come ... meter in size. Yet, as director of Northwestern University,s ... is anything but small. A prolific inventor and entrepreneur, ... of medical diagnostics and patient point-of-care and to ignite ...
Cached Medicine News:Health News:Toray to establish water treatment R&D center at NTU in Singapore 2Health News:Toray to establish water treatment R&D center at NTU in Singapore 3Health News:National Physician Summit & Petition: 'Take Back Medicine' 6/25/09 2Health News:Quest Diagnostics Earns Platinum Honor As 'Best Employer For Healthy Lifestyles' 2Health News:Quest Diagnostics Earns Platinum Honor As 'Best Employer For Healthy Lifestyles' 3Health News:Quest Diagnostics Earns Platinum Honor As 'Best Employer For Healthy Lifestyles' 4Health News:Quest Diagnostics Earns Platinum Honor As 'Best Employer For Healthy Lifestyles' 5Health News:PATHFAST(R) Rapid Whole Blood Immunoassay Analyzer from Polymedco 2Health News:World-renowned nanotechnology expert proves there is big potential in the smallest of matter 2Health News:World-renowned nanotechnology expert proves there is big potential in the smallest of matter 3Health News:World-renowned nanotechnology expert proves there is big potential in the smallest of matter 4
ROB-NEL Catheters (100% Latex-Free)...
Urethral Red Rubber Catheters (Latex)...
ULTRAMER Foley Catheter...
Silicone-Coated Foley Catheter 2-Way...
Medicine Products: